We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The FDA has revealed that it plans to terminate its "alternative summary reporting" programme which has allowed the manufacturers of medical devices to keep undesirable reports of malfunctions and adverse events out of public knowledge.
Incyte announced that David Gryska, Executive Vice President and Chief Financial Officer, intends to retire at the end of 2018 and that Incyte has launched a search for his replacement.